Renal sympathetic denervation improves cardiac dysfunction in rats with chronic pressure overload

Physiological Research

Volumn 64, Issue 5, 2015, Pages 653-662

  Li, Z Z ^a   Jiang, H ^a   Chen, D ^b   Liu, Q ^a   Geng, J ^a   Guo, J Q ^a   Sun, R H ^a   Zhu, G Q ^b   Shan, Q J ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac dysfunction; Remodeling; Renal sympathetic denervation

Indexed keywords

ADRENERGIC SYSTEM; ANIMAL; CARDIAC MUSCLE CELL; CHRONIC DISEASE; HEART FAILURE; HYPERTROPHY, LEFT VENTRICULAR; INNERVATION; KIDNEY; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPRAGUE DAWLEY RAT; SYMPATHECTOMY; TRENDS;

ANIMALS; CHRONIC DISEASE; HEART FAILURE; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; MALE; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84984939491     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Balt J.C., Mathy M.J., Nap A., Pfaffendorf M., Van Zwieten P.A.: Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. J Cardiovasc Pharmacol 38: 141-148, 2001.
2. Bhatt D.L., Kandzari D.E., O'neill W.W., D'agostino R., Flack J.M., Katzen B.T., Leon M.B., Liu M., Mauri L., Negoita M., Cohen S.A., Oparil S., Rocha-Singh K., Townsend R.R., Bakris G.L.; Symplicity HTN-3 Investigators: A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370: 1393-1401, 2014.
3. Brandt M.C., Mahfoud F., Reda S., Schirmer S.H., Erdmann E., Bohm M., Hoppe U.C.: Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 59: 901-909, 2012.
4. Bristow M.R.: The adrenergic nervous system in heart failure. N Engl J Med 311: 850-851, 1984.
5. Bruno R.M., Taddei S.: Renal denervation and regression of left ventricular hypertrophy. Eur Heart J 35: 2205-2207, 2014.
6. Chen W.W., Sun H.J., Zhang F., Zhou Y.B., Xiong X.Q., Wang J.J., Zhu G.Q.: Salusin-ß in paraventricular nucleus increases blood pressure and sympathetic outflow via vasopressin in hypertensive rats. Cardiovasc Res 98: 344-351, 2013.
7. Chen Y., Li Y., Guo L., Chen W., Zhao M., Gao Y., Wu A., Lou L., Wang J., Liu X., Xing Y.: Effects of wenxin keli on the action potential and L-type calcium current in rats with transverse aortic constriction-induced heart failure. Evid Based Complement Alternat Med 2013: 572078, 2013.
8. Dibona G.F.: Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension 36: 1083-1088, 2000.
9. Dibona G.F., Sawin L.L.: Frequency response of the renal vasculature in congestive heart failure. Circulation 107: 2159-2164, 2003.
10. Fort P., Marty L., Piechaczyk M., El Sabrouty S., Dani C., Jeanteur P., Blanchard J.M.: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 13: 1431-1442, 1985.
11. Fredersdorf S., Thumann C., Zimmermann W.H., Vetter R., Graf T., Luchner A., Riegger G.A., Schunkert H., Eschenhagen T., Weil J.: Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data. Cardiovasc Diabetol 11: 57, 2012.
12. Gelpi R.J., Park M., Gao S., Dhar S., Vatner D.E., Vatner S.F.: Apoptosis in severe, compensated pressure overload predominates in nonmyocytes and is related to the hypertrophy but not function. Am J Physiol Heart Circ Physiol 300: H1062-H1068, 2011.
13. Granger J., Novak J., Schnackenberg C., Williams S., Reinhart G.A.: Role of renal nerves in mediating the hypertensive effects of nitric oxide synthesis inhibition. Hypertension 27: 613-618, 1996.
14. Hu J., Ji M., Niu C., Aini A., Zhou Q., Zhang L., Jiang T., Yan Y., Hou Y.: Effects of renal sympathetic denervation on post-myocardial infarction cardiac remodeling in rats. PloS One 7: e45986, 2012.
15. Hu J., Yan Y., Zhou Q., Ji M., Niu C., Hou Y., Ge J.: Effects of renal denervation on the development of postmyocardial infarction heart failure and cardiac autonomic nervous system in rats. Int J Cardiol 172: e414-e416, 2014.
16. Jackson G., Gibbs C.R., Davies M.K., Lip G.Y.: ABC of heart failure. Pathophysiology. BMJ 320: 167-170, 2000.
17. Jiang W., Tan L., Guo Y., Li X., Tang X., Yang K.: Effect of renal denervation procedure on left ventricular hypertrophy of hypertensive rats and its mechanisms. Acta Cir Bras 27: 815-820, 2012.
18. Johnston C.I., Arnolda L., Abrahams J., Mcgrath B.: Role of vasopressin in experimental congestive cardiac failure. J Cardiovasc Pharmacol 8 (Suppl 7): S9-S100, 1986.
19. Kassab S., Kato T., Wilkins F.C., Chen R., Hall J.E., Granger J.P.: Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 25: 893-897, 1995.
20. Kiuchi K., Shannon R.P., Komamura K., Cohen D.J., Bianchi C., Homcy C.J., Vatner S.F., Vatner D.E.: Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest 91: 907-914, 1993.
21. Lymperopoulos A., Rengo G., Koch W.J.: Adrenergic nervous system in heart failure: Pathophysiology and therapy. Circ Res 113: 739-753, 2013.
22. Mann D.L., Bristow M.R.: Mechanisms and models in heart failure: The biomechanical model and beyond. Circulation 111: 2837-2849, 2005.
23. Mcmurray J.J., Pfeffer M.A.: Heart failure. Lancet 365: 1877-1889, 2005.
24. Naitoh M., Suzuki H., Murakami M., Matsumoto A., Arakawa K., Ichihara A., Nakamoto H., Oka K., Yamamura Y., Saruta T.: Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. Am J Physiol 267: H2245-H2254, 1994.
25. Nielsen S., Chou C.L., Marples D., Christensen E.I., Kishore B.K., Knepper M.A.: Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci U S A 92: 1013-1017, 1995.
26. Port J.D., Bristow M.R.: Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol 33: 887-905, 2001.
27. Rona G.: Catecholamine cardiotoxicity. J Mol Cell Cardiol 17: 291-306, 1985.
28. Schirmer S.H., Sayed M.M., Reil J.C., Ukena C., Linz D., Kindermann M., Laufs U., Mahfoud F., Bohm M.: Improvements in left ventricular hypertrophy and diastolic function following renal denervation: Effects beyond blood pressure and heart rate reduction. J Am Coll Cardiol 63: 1916-1923, 2014.
29. Schmitz W., Boknik P., Linck B., Muller F.U.: Adrenergic and muscarinic receptor regulation and therapeutic implications in heart failure. Mol Cell Biochem 157: 251-258, 1996.
30. Schrier R.W.: Role of diminished renal function in cardiovascular mortality: Marker or pathogenetic factor? J Am Coll Cardiol 47: 1-8, 2006.
31. Schrier R.W., Abraham W.T.: Hormones and hemodynamics in heart failure. N Engl J Med 341: 577-585, 1999.
32. Sobotka P.A., Krum H., Bohm M., Francis D.P., Schlaich M.P.: The role of renal denervation in the treatment of heart failure. Curr Cardiol Rep 14: 285-292, 2012.
33. Troispoux C., Reit Er E., Combarnous Y., Guillou F.: Beta2 adrenergic receptors mediate cAMP, tissue-type plasminogen activator and transferrin production in rat Sertoli cells. Mol Cell Endocrinol 142: 75-86, 1998.
34. Weinberg E.O., Schoen F.J., George D., Kagaya Y., Douglas P.S., Litwin S.E., Schunkert H., Benedict C.R., Lorell B.H.: Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 90: 1410-1422, 1994.
35. Yao Y., Fomison-Nurse I.C., Harrison J.C., Walker R.J., Davis G., Sammut I.A.: Chronic bilateral renal denervation attenuates renal injury in a transgenic rat model of diabetic nephropathy. Am J Physiol Renal Physiol 307: F251-F262, 2014.
36. Zhang S., Zhang F., Sun H., Zhou Y., Han Y.: Enhanced sympathetic activity and cardiac sympathetic afferent reflex in rats with heart failure induced by adriamycin. J Biomed Res 26: 425-431, 2012.
37. Zhao J., Araki N., Nishimoto S.K.: Quantitation of matrix Gla protein mRNA by competitive polymerase chain reaction using glyceraldehyde-3-phosphate dehydrogenase as an internal control. Gene 155: 159-165, 1995.